CCL1 level was observed to be higher in AD compared to controls and MCI in the transition from MCI to AD, regardless of age, sex, or APOE genotype, at each of the baseline, 18-, and 36-month sampling periods [60]. The gene discussed is APOE; the disease is Alzheimer disease.